Cibus Announces Election of New Board Member, Deepening Strategic Leadership and Experience SAN DIEGO , Sept. 18, 2023 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ: CBUS), a global leader in Gene Editing in agriculture and the development of Productivity Traits in plants that directly impact farming
SAN DIEGO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that Rory Riggs, Co-Founder, Chief Executive Officer, and Chairman, will present at H.C.
Two gene editing pioneers closed merger to create a leading agricultural gene editing company with an expanded portfolio of patents, patents pending, and exclusive licenses to core technologies for gene editing of plants. Important greenhouse data continues to show promising results for Cibus’
Former General Counsel for Syngenta Crop Protection LLC joins Cibus to help develop its commercial business and accompanying growth in its legal and IP activities SAN DIEGO, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) , a leading agricultural technology company that develops and
SAN DIEGO, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that the company will report second quarter 2023 financial results on Thursday, August 10, 2023.
SAN DIEGO, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that Rory Riggs, Co-Founder, Chief Executive Officer, and Chairman, will present at the Canaccord 43 rd
The Facility represents the first semi-automated gene editing trait production system that provides a time-bound, predictable and reproducible breeding system for the editing of commercial plants. The Facility’s Trait Machine TM process edits directly into a customers’ elite germplasm, increasing
Proposal aims to adapt EU legislation to scientific and technological progress, enabling the products of New Genomic Techniques (NGTs) to contribute to more sustainable agriculture, climate resilience, and food security Proposed regulation identifies a ‘Conventional-like’ category of NGT products
Provisions of Act aim to facilitate development and marketing of gene edited crops in the United Kingdom The Act aligns regulation of new technologies such as Cibus’ gene editing platform to conventional breeding SAN DIEGO , June 15, 2023 (GLOBE NEWSWIRE) -- Cibus, Inc.
